N2N Technologies Limited Open Offer Commences: Harmony Remedies Seeks 40% Stake at ₹4.30 Per Share
Harmony Remedies India Private Limited has commenced a mandatory open offer to acquire 12,91,228 equity shares of N2N Technologies Limited at ₹4.30 per share, representing 40% of expanded voting capital. The independent directors' committee has deemed the offer price fair and reasonable, considering the company's suspended trading status. The tendering period runs from April 30 to May 14, 2026, with settlement by May 29, 2026.

*this image is generated using AI for illustrative purposes only.
Harmony Remedies India Private Limited has launched a mandatory open offer to acquire a significant stake in N2N Technologies Limited, targeting up to 12,91,228 equity shares at ₹4.30 per share. The offer, which represents 40% of the expanded voting capital, is being conducted under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Open Offer Details
The acquisition is being managed by Inga Ventures Private Limited, with Harmony Remedies acting alongside persons acting in concert (PACs) Mr. Firoze Nariman Kapadia and Ms. Aditi Vipin Parikh, who serve as representing directors of the acquirer. The offer follows a mandatory requirement under Regulation 4 of the SEBI (SAST) Regulations.
| Parameter: | Details |
|---|---|
| Target Shares: | 12,91,228 equity shares |
| Face Value: | ₹10 per share |
| Offer Price: | ₹4.30 per share |
| Voting Capital: | 40% of expanded voting capital |
| Offer Type: | Mandatory under Regulation 4 |
Independent Directors' Recommendation
The committee of independent directors of N2N Technologies Limited has evaluated the offer and provided its recommendation. The committee, comprising Mr. Vijay Shivanand Waingankar as Chairman and Mr. Venkatchalam Raman as Member, has deemed the offer price fair and reasonable.
The IDC noted that the equity shares of the target company are currently suspended from trading and reviewed the quantum of trading and relevant prices on BSE Limited. Since the shares are not frequently traded, the price determination took into account a report on fair value issued by Maheshwari & Co. Chartered Accountants dated October 17, 2025.
Tendering Process and Timeline
The offer opening public announcement was published on April 29, 2026, in multiple newspapers including Financial Express (English national daily), Jansatta (Hindi national daily), Tarun Bharat (Marathi - Pune edition), and Navshakti (Marathi - Mumbai edition).
| Activity: | Date | Day |
|---|---|---|
| Offer Opening Date: | April 30, 2026 | Thursday |
| Offer Closing Date: | May 14, 2026 | Thursday |
| Settlement Date: | May 29, 2026 | Friday |
| Post-Offer Announcement: | June 05, 2026 | Friday |
Public shareholders holding shares in dematerialized form must approach their respective selling brokers to tender their shares before market hours close on the last day of the tendering period. Those holding physical shares need to submit original share certificates along with duly executed transfer forms and other required documents.
Current Status and Regulatory Updates
N2N Technologies Limited's equity shares are presently under suspension from trading due to non-payment of annual listing fees under Regulation 14 of SEBI (LODR) Regulations. The company has filed a revocation of suspension application with BSE on October 24, 2025. The acquirer has paid pending annual listing fees of ₹11,28,314 on November 27, 2025, though outstanding SOP fines totaling ₹8,43,488 (including GST) remain payable.
The Letter of Offer dated April 20, 2026, has been dispatched to all public shareholders as of the identified date (April 16, 2026). The offer is not conditional upon any minimum level of acceptance and no competing offers have been announced. SEBI provided its final observations on the draft letter of offer on April 13, 2026, and all regulatory comments have been incorporated into the final documentation.
Will N2N Technologies' trading suspension be lifted after the outstanding SOP fines are cleared, and how might this affect the stock's liquidity post-acquisition?
What strategic synergies does Harmony Remedies expect to achieve with N2N Technologies, and could this signal further consolidation in their industry sector?
How might the significant discount between the offer price (₹4.30) and face value (₹10) impact minority shareholder participation in the tender offer?
























